JR Rahn is the founder of MindMed
In the Mission: MindMed’s goal is to develop and deliver psychedelic inspired medicines that ease suffering and improve healthcare.. Our products are used in a wide range of markets including adult ADHD, addictions, and headache clusters..”
COVID-19 Impact on the Economy: COVID-19 has a lasting effect on mental health around the globe. Overdose deaths have increased by as much as 60 percent in some municipalities. COVID-19 can have more serious side effects on mental health than the actual virus.”
On Industry The psychedelics are gaining momentum, and this is especially true when people attempt to compare the drug to cannabis. The industry will one day reach a level of maturity that is unimaginable.If the statistics prove that we can end society’s battle with mental illnesses, then cannabis is not even close to being comparable..”
Rick Doblin is the founder and executive director of MAPS
What to Look for When Choosing MDMA We did an analysis of the patient populations we would target first, and which psychedelics were likely to make it past regulatory systems.. On the basis of that I thought that MDMA would be the best drug. It is the gentlest and easiest psychedelic to use, and it’s also the most therapeutic..”
The Mechanism of Action The brains of PTSD sufferers are altered by PTSD, and MDMA is able to change them back almost exactly in the same way.. Thus, MDMA can decrease activity of the amygdala in PTSD (the part of your brain that processes fear).. PTSD lowers prefrontal activity (where we can think logically), MDMA raises prefrontal activity.”
The Business Model We have refused to accept money offered by investors in order to gain approval from Europe and the US.. We think we can do it differently from the for-profits. Our pricing is just one example. Investors won’t have to pay back the entire amount..”